Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A novel iodine-containing antiviral drug

An antiviral drug, a technology of chemical structural formula, applied in the direction of antiviral agents, active ingredients of iodine compounds, pharmaceutical formulations, etc., can solve the problem of no effect on the nuclear cccDNA library, and achieve the effect of good physiological activity and reduced activity

Active Publication Date: 2022-08-05
THE THIRD AFFILIATED HOSPITAL OF SUN YAT SEN UNIV
View PDF11 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] The defect of the above-mentioned technical scheme is: the existing clinical anti-HBV drugs have no effect on the cccDNA pool in the nucleus

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A novel iodine-containing antiviral drug
  • A novel iodine-containing antiviral drug
  • A novel iodine-containing antiviral drug

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0031] The present embodiment provides a novel iodine-containing antiviral drug, the general chemical structure of which is shown in formula 1, including:

[0032] Bonding groups for binding viral genetic material;

[0033] The iodine group used to destroy viral genetic material.

[0034] Among them, the bonding group includes two hydroxyl groups, which can be combined with a phosphorus atom to form a phosphodiester bond.

[0035] The iodine element in the iodo group is the stable isotope of iodine 127 I.

[0036] Cell experiments were performed with the above-mentioned iodine-containing antiviral drugs, and anti-HBV activity tests were performed; the results compared with other drugs are as follows:

[0037] 1. Comparison of the effects of iodine-containing antiviral drugs and entecavir in inhibiting the expression of HBV cccDNA image 3 Shown: cccDNA expression was measured at 48h and 72h after adding iodine-containing antiviral drugs and entecavir, respectively. The res...

Embodiment 2

[0042] The difference between this example and Example 1 is that the iodine element in the iodo group is a radioisotope of iodine 125 I.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention provides a novel iodine-containing antiviral drug, the general chemical structure of which is shown in formula 1, including: a bond-forming group for binding viral genetic material; and an iodine group for destroying viral genetic material. The invention has better physiological activity and is expected to become a new type of anti-hepatitis B virus drug.

Description

technical field [0001] The invention relates to a novel iodine-containing antiviral drug. Background technique [0002] Hepatitis B (hepatitis B for short) is an infectious disease caused by hepatitis B virus (Hepatitis B Virus, HBV) infection. Liver disease, liver cirrhosis, and liver cancer are an important public health problem worldwide. my country is a high incidence area of ​​hepatitis B. The results of the second HBV infection seroepidemiological survey in my country show that there are about 120 million HBV carriers in the country, and the HBV infection rate accounts for about 3.2% of the total population, with a total of about 42 million, most of whom are chronic. persistent infection. [0003] Covalently closed circular DNA (cccDNA) is an important cause of persistent chronic hepatitis B infection and the main cause of relapse after antiviral therapy. The cellular immune response triggered by it can not only cause liver parenchyma damage, but also lead to Chronic...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/519A61K33/18A61P31/20
CPCA61K31/519A61K33/18A61P31/20
Inventor 谢良骏
Owner THE THIRD AFFILIATED HOSPITAL OF SUN YAT SEN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com